Of cryptogenic stroke patients younger than 55 years of age, up to 61% have had a patent
foramen ovale (PFO). Observational studies have revealed reductions in recurrent …

Transcatheter closure of patent foramen ovale (PFO) in patients with cryptogenic stroke is
gaining momentum after the recent publication of four randomized clinical trials suggesting …

Background In patients with cryptogenic stroke, transcatheter (TC) closure of a patent
foramen ovale (PFO) has not been shown to better prevent recurrent vascular events than …

The purpose of this study was to assess the safety and feasibility of percutaneous
interventional closure of patent foramen ovale (PFO) with or without atrial septal aneurysm …

Background: Recent reports showing the favorable role of patent foramen ovale (PFO)
closure in patients with cryptogenic stroke have raised the issue of selecting optimal …

Patent foramen ovales (PFOs) are common congenital cardiac defects that are more
prevalent among patients experiencing cryptogenic stroke than among those with strokes of …

Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of
the adult population. For most people, it is a benign finding; however, in some people, the …

Closure of patent foramen ovale (PFO) has been proposed as an alternative to
anticoagulation in patients with presumed paradoxical emboli. We report the immediate and …

Foramen ovale is an embryonic defect in the interatrial septum which allows passage of
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …

Background and Purpose—We sought to evaluate the real-world rate of safety outcomes
after patent foramen ovale (PFO) closure in patients with ischemic stroke or transient …